# Bioequivalence Study of Two Products of Tenofovir Alafenamide 25 mg Film Tablet in Healthy, Adult, Human Subjects

> **NCT06592300** · PHASE1 · COMPLETED · sponsor: **Humanis Saglık Anonim Sirketi** · enrollment: 42 (actual)

## Conditions studied

- Chronic Hepatitis B in Adults and Paediatric Patients

## Interventions

- **DRUG:** Tenofovir Alafenamide Film coated Tablet
- **DRUG:** Vemlidy® film-coated tablets

## Key facts

- **NCT ID:** NCT06592300
- **Lead sponsor:** Humanis Saglık Anonim Sirketi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-06
- **Primary completion:** 2024-08-02
- **Final completion:** 2024-09-13
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2025-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06592300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06592300, "Bioequivalence Study of Two Products of Tenofovir Alafenamide 25 mg Film Tablet in Healthy, Adult, Human Subjects". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT06592300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*